The University of Arizona
Map Home
Loading...
Adjust height of sidebar
KMap

Grant

Titin-Based Stiffness Regulation and Mechanosensing in Activated Skeletal Muscle.

Sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases

Active
$1.3M Funding
3 People
External

Related Topics

Abstract

Titin is the third myofilament of skeletal muscle where it spans the I-band and A-band regions of the sarcomere.Multiple titin mutations have been described that result in debilitating myopathies highlighting titin's importancein skeletal muscle and the need to understand all of titin's functions fully. Our current understanding of titin islargely based on studying passive skeletal muscle and assuming that no established properties change whenskeletal muscle is activated. However recent studies suggest that titin's I-band segment interacts with the thinfilament in contracting or diseased muscle altering titin's extensibility from that in passive muscle and impactingpassive force and thick filament activation. Possible thin filament interaction sites are the PEVK element and theN2A of skeletal muscle the latter is part of a recently discovered novel stiffness regulation mechanism thatinvolves MARP1 a stress response protein. Using mouse models aims 1 and 2 focus on the roles of the N2Aand PEVK elements in regulating titin stiffness in skeletal muscle including the effects of upregulating MARP.We also study the role of titin in activating the thick filament in skeletal muscle. Important work in the myosin fieldhas shown that muscle activation requires thin filament activation (as is well-known) and thick filament activationmechanisms (a more recent discovery). In relaxed skeletal muscle myosin is either in the super-relaxed (SRX)state or the disordered-relaxed (DRX) state. The conversion of SRX to DRX turns thick filaments ON promotingcontraction. Several mechanisms have been proposed to regulate the ON state of the skeletal muscle thickfilament including a mechano-sensing mechanism that involves thick filament strain. We have previouslyobtained evidence that titin-based passive force strains the skeletal muscle thick filament. Aim three will test thehypothesis that this converts SRX to DRX myosin in skeletal muscle and switches the thick filament from OFFto ON. High-resolution ATP turnover assays have revealed that although the SRX state occurs in each of the A-band regions of skeletal muscle (the D-zone C-zone and P-zone) the C-zone has the highest level. In additionto titin the C-zone contains MyBP-C. Aim 4 will study the importance of each in SRX. It will also address theeffect of locally perturbing titin strain (by deleting single C-zone domains) on SRX in skeletal muscle. This workhas high novelty and addresses fundamental questions that have clinical relevance. All required models andtools are available an experienced team of collaborators is in place and extensive pilot data support the guidinghypotheses of the proposed research. This proposal is a significant step towards our long-term goal which is togain a detailed understanding of the roles of titin in both passive and active skeletal muscle and contribute to ourunderstanding of the mechanistic basis of skeletal muscle disease.

People